The Stakeholder Consultation on Drug Serialization and Traceability in India, hosted by the Indian Council for Research on International Economic Relations (ICRIER) and RxGPS, was held on 3 March, 2017 in New Delhi to discuss India’s serialization and traceability requirements. The Stakeholder Consultation was attended by more than 60 representatives of the Indian and global pharmaceutical markets, patient and public health advocates, global regulatory authorities, and Indian regulators. This white paper captures the dialogue and conclusions of the Stakeholder Consultation and sets forth a roadmap for strengthening the Indian pharmaceutical serialization and traceability system.